We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Waste Management
WM
$85.5B
| $10.2M | 0.02% |
47,596
+431
| +0.9% | +$89.6K |
|
552
Charles River Laboratories
CRL
$13.1B
| $10.2M | 0.02% |
49,140
-39
| -0.1% | -$8.84K |
|
553
Tenet Healthcare
THC
$21.4B
| $10.1M | 0.02% |
75,975
-62,614
| -45% | -$7.54M |
|
554
Cboe Global Markets
CBOE
$28.2B
| $10.1M | 0.02% |
59,310
-1,339
| -2% | -$238K |
|
555
Kirby Corp
KEX
$7.23B
| $10.1M | 0.02% |
84,093
-5,015
| -6% | -$560K |
|
|
P
556
Everpure Inc
P
$32.5B
| $10M | 0.02% |
156,431
+113,603
| +265% | +$6.57M |
|
|
REVG
557
DELISTED
REV Group
REVG
| $10M | 0.02% |
403,379
-35,088
| -8% | -$861K |
|
558
Enphase Energy
ENPH
$4.7B
| $10M | 0.02% |
100,664
-12,787
| -11% | -$1.49M |
|
559
Corebridge Financial
CRBG
$15.5B
| $9.97M | 0.02% |
342,226
+211,709
| +162% | +$6.09M |
|
560
Aon
AON
$63.8B
| $9.95M | 0.02% |
33,888
-15,625
| -32% | -$4.62M |
|
561
ON Semiconductor
ON
$25.9B
| $9.9M | 0.02% |
144,383
+115,972
| +408% | +$8.14M |
|
562
Trustmark
TRMK
$2.74B
| $9.89M | 0.02% |
329,281
+45
| +0% | +$1.29K |
|
563
iShares MBS ETF
MBB
$38.9B
| $9.85M | 0.02% |
107,250
+40,950
| +62% | +$3.73M |
|
564
Atmus Filtration Technologies
ATMU
$3.61B
| $9.74M | 0.02% |
338,597
+313,969
| +1,275% | +$9.52M |
|
565
AvePoint
AVPT
$2.84B
| $9.74M | 0.02% |
934,670
+32,821
| +4% | +$285K |
|
566
Pultegroup
PHM
$22.4B
| $9.67M | 0.02% |
87,811
-13,126
| -13% | -$1.49M |
|
567
Masco
MAS
$13.5B
| $9.65M | 0.02% |
144,767
+122,998
| +565% | +$8.67M |
|
568
Pentair
PNR
$9.01B
| $9.61M | 0.02% |
125,392
-1,582
| -1% | -$127K |
|
569
PROG Holdings
PRG
$1.42B
| $9.59M | 0.02% |
276,536
-91,782
| -25% | -$3.18M |
|
570
W.W. Grainger
GWW
$59.3B
| $9.58M | 0.02% |
10,614
+523
| +5% | +$492K |
|
571
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
| $9.57M | 0.02% |
323,207
-49,621
| -13% | -$1.45M |
|
572
CarGurus
CARG
$3.09B
| $9.54M | 0.02% |
364,287
-110,677
| -23% | -$2.63M |
|
573
Bankunited
BKU
$3.17B
| $9.54M | 0.02% |
325,812
+317,143
| +3,658% | +$8.83M |
|
574
Cimpress
CMPR
$1.98B
| $9.39M | 0.02% |
107,171
-134
| -0.1% | -$11.7K |
|
575
Shell
SHEL
$274B
| $9.35M | 0.02% |
129,475
-1,971
| -1% | -$141K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.